“Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker”, AWMR, vol. 1, no. 2, pp. 48–63, Dec. 2025, doi: 10.71204/1bcv8650.